Faculty Publications
As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.
Total number of publications: 7,082
Enter a faculty name:
or browse faculty by school:
Administrative Offices
Graduate Schools
Health Sciences
Lander Colleges
Law Center
New York School of Career and Applied Studies (NYSCAS)
Touro University System
New York Medical College (NYMC)
Touro University California
Touro University Nevada
Aronow, W. S. (2015). Multiple blood pressure medications and mortality among elderly individuals. JAMA, 313(13), 1362-1363. doi:10.1001/jama.2015.248
Aronow, W. S. (2015). Neurogenic stress cardiomyopathy associated with subarachnoid hemorrhage. Future Cardiology, 11(1), 77-87. doi:10.2217/fca.14.73
Aronow, W. S. (2015). Newer targets and therapies for hypertension and dyslipidemia in diabetic patients. Cardiovascular Endocrinology, 4(1), 11-16. doi:10.1097/XCE.0000000000000043
Aronow, W. S. (2015). Optimal systolic blood pressure goal in persons aged 60 years and older. Annals of Clinical and Experimental Hypertension, 3(2), 1023. This material can be found here.
Aronow, W. S. (2015). PCSK9 inhibitors. Cardiovascular Pharmacology Open Access, 4, [Article e128]. doi:10.4172/2329-6607.1000e128
Aronow, W. S. (2015). Regional differences in heart failure with preserved ejection fraction trials. Journal of Cardiovascular Disorders, 2(1), [Article 1008]. doi:10.1161/CIRCULATIONAHA.114.013637
Aronow, W. S. (2015). Review of 2003 to 2015 guidelines on treatment of hypertension in patients with coronary artery disease. Journal of Hypertension and Management, 1(1), [Article 1]. This material can be found here.
Aronow, W. S. (2015). Thoracic aortic aneurysm. Angiology Open Access, 3, [Article e113]. doi:10.4172/2329-9495.1000e113
Aronow, W. S. (2015). Treating hypertension and prehypertension in older people: When, whom and how. Maturitas, 80(1), 31-36. doi:10.1016/j.maturitas.2014.10.001
Aronow, W. S. (2015). Treatment of cardiac hemochromatosis. Heart Research Open Journal, 2(3), e3-e5. doi:10.17140/HROJ-2-e002
Aronow, W. S. (2015). Treatment of hypertension in persons with coronary artery disease: What the guidelines recommend. Consultant, 55(10), 803-808. This material can be found here.
Aronow, W. S. (2015). Treatment of intermittent claudication due to peripheral arterial disease. Angiology Open Access, 3(1), [Article e111]. doi:10.4172/2329-9495.1000e111
Aronow, W. S. (2015). Treatment of lower extremity peripheral arterial disease. International Heart and Vascular Disease Journal, 3(5), 3-14. This material can be found here.
Aronow, W. S. (2015). Update on management of aneurysms of the abdominal aorta, its branch vessels, and the lower extremities. Angiology Open Access, 3(1), [Article e109]. doi:10.4172/2329-9495.1000e109
Aronow, W. S. (2015). What should the hemoglobin A1c level goal be in diabetics? International Journal of Diabetology & Vascular Disease Research, 3(10), 137-139. doi:10.19070/2328-353X-1500029
Aronow, W. S. (2015). White coat hypertension. Insights in Blood Pressure, 1(1), [Article 6]. This material can be found here.
Aronow, W. S. (2016). 2016 update on treatment of hypertension. Cardiology, 134(Suppl 1), 317.
Aronow, W. S. (2016). Current treatment of heart failure with reduction of left ventricular ejection fraction. Expert Review of Clinical Pharmacology, 9(12), 1619-1631. doi:10.1080/17512433.2016.1242067
Aronow, W. S. (2016). Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines. Expert Opinion on Pharmacotherapy, 17(2), 205-215. doi:10.1517/14656566.2015.1091881
Aronow, W. S. (2016). Editor note: Early diagnosis to reduce CVD mortality. Journal of Cardiovascular Diseases & Diagnosis, 4(4), e113. doi:10.4172/2329-9517.1000e113
Aronow, W. S. (2016). Exercise rehabilitation for the treatment of intermittent claudication due to peripheral arterial disease of the lower extremities. Vascular Diseases and Therapeutics,1(1) doi:10.15761/VDT.1000101
Aronow, W. S. (2016). Fractional flow reserve. ARC Journal of Cardiology, 2(1), 7-10. doi:10.20431/2455-5991.0201005
Aronow, W. S. (2016). Iron chelation therapy for treatment of cardiac hemochromatosis. Journal of Clinical and Experimental Cardiology, 7(3), e142. doi:10.4172/2155-9880.1000e142
Aronow, W. S. (2016). Lower extremity peripheral arterial disease management. Gavin Journal of Cardiology and Cardiovascular Diseases, 2016(1), 5-11. This material can be found here.
Aronow, W. S. (2016). Nonalcoholic fatty liver disease is associated with coronary artery disease and subclinical atherosclerosis. Future Cardiology, 12(4), 393-396. doi:10.2217/fca-2016-0033
